169 related articles for article (PubMed ID: 27904474)
21. [Neuronal death: potential role of the nuclear enzyme, poly (ADP-ribose) polymerase].
Boulu RG; Mesenge C; Charriaut-Marlangue C; Verrecchia C; Plotkine M
Bull Acad Natl Med; 2001; 185(3):555-63; discussion 564-5. PubMed ID: 11501263
[TBL] [Abstract][Full Text] [Related]
22. The role of NADPH oxidase, neuronal nitric oxide synthase and poly(ADP ribose) polymerase in oxidative neuronal death induced in cortical cultures by brain-derived neurotrophic factor and neurotrophin-4/5.
Hwang JJ; Choi SY; Koh JY
J Neurochem; 2002 Aug; 82(4):894-902. PubMed ID: 12358795
[TBL] [Abstract][Full Text] [Related]
23. PARP inhibitors attenuate chemotherapy-induced painful neuropathy.
Brederson JD; Joshi SK; Browman KE; Mikusa J; Zhong C; Gauvin D; Liu X; Shi Y; Penning TD; Shoemaker AR; Giranda VL
J Peripher Nerv Syst; 2012 Sep; 17(3):324-30. PubMed ID: 22971094
[TBL] [Abstract][Full Text] [Related]
24. Differentiation-Associated Downregulation of Poly(ADP-Ribose) Polymerase-1 Expression in Myoblasts Serves to Increase Their Resistance to Oxidative Stress.
Oláh G; Szczesny B; Brunyánszki A; López-García IA; Gerö D; Radák Z; Szabo C
PLoS One; 2015; 10(7):e0134227. PubMed ID: 26218895
[TBL] [Abstract][Full Text] [Related]
25. Chronic PARP-1 inhibition reduces carotid vessel remodeling and oxidative damage of the dorsal hippocampus in spontaneously hypertensive rats.
Eros K; Magyar K; Deres L; Skazel A; Riba A; Vamos Z; Kalai T; Gallyas F; Sumegi B; Toth K; Halmosi R
PLoS One; 2017; 12(3):e0174401. PubMed ID: 28339485
[TBL] [Abstract][Full Text] [Related]
26. Poly(ADP-ribose) polymerase 1 inhibition protects cardiomyocytes from inflammation and apoptosis in diabetic cardiomyopathy.
Qin WD; Liu GL; Wang J; Wang H; Zhang JN; Zhang F; Ma Y; Ji XY; Li C; Zhang MX
Oncotarget; 2016 Jun; 7(24):35618-35631. PubMed ID: 27027354
[TBL] [Abstract][Full Text] [Related]
27. Role of nitrosative stress and activation of poly(ADP-ribose) polymerase-1 in cardiovascular failure associated with septic and hemorrhagic shock.
Evgenov OV; Liaudet L
Curr Vasc Pharmacol; 2005 Jul; 3(3):293-9. PubMed ID: 16026325
[TBL] [Abstract][Full Text] [Related]
28. Minocycline inhibits poly(ADP-ribose) polymerase-1 at nanomolar concentrations.
Alano CC; Kauppinen TM; Valls AV; Swanson RA
Proc Natl Acad Sci U S A; 2006 Jun; 103(25):9685-90. PubMed ID: 16769901
[TBL] [Abstract][Full Text] [Related]
29. Poly(ADP-ribose) polymerase inhibition suppresses inflammation and promotes recovery from adrenal injury in a rat model of acute necrotizing pancreatitis.
Yu J; Zuo T; Deng W; Shi Q; Ma P; Chen C; Zhao L; Zhao K; Wang W
BMC Gastroenterol; 2016 Jul; 16(1):81. PubMed ID: 27465581
[TBL] [Abstract][Full Text] [Related]
30. Hypoglycemic neuronal death and cognitive impairment are prevented by poly(ADP-ribose) polymerase inhibitors administered after hypoglycemia.
Suh SW; Aoyama K; Chen Y; Garnier P; Matsumori Y; Gum E; Liu J; Swanson RA
J Neurosci; 2003 Nov; 23(33):10681-90. PubMed ID: 14627653
[TBL] [Abstract][Full Text] [Related]
31. Role of poly(ADP-ribose) synthetase in inflammation and ischaemia-reperfusion.
Szabó C; Dawson VL
Trends Pharmacol Sci; 1998 Jul; 19(7):287-98. PubMed ID: 9703762
[TBL] [Abstract][Full Text] [Related]
32. Poly(ADP-ribose) polymerase inhibition alleviates experimental diabetic sensory neuropathy.
Ilnytska O; Lyzogubov VV; Stevens MJ; Drel VR; Mashtalir N; Pacher P; Yorek MA; Obrosova IG
Diabetes; 2006 Jun; 55(6):1686-94. PubMed ID: 16731831
[TBL] [Abstract][Full Text] [Related]
33. Concurrent targeting of nitrosative stress-PARP pathway corrects functional, behavioral and biochemical deficits in experimental diabetic neuropathy.
Negi G; Kumar A; Sharma SS
Biochem Biophys Res Commun; 2010 Jan; 391(1):102-6. PubMed ID: 19900402
[TBL] [Abstract][Full Text] [Related]
34. Role of redox signaling and poly (adenosine diphosphate-ribose) polymerase activation in vascular smooth muscle cell growth inhibition by nitric oxide and peroxynitrite.
Huang J; Lin SC; Nadershahi A; Watts SW; Sarkar R
J Vasc Surg; 2008 Mar; 47(3):599-607. PubMed ID: 18295111
[TBL] [Abstract][Full Text] [Related]
35. PARP inhibitors: new tools to protect from inflammation.
Giansanti V; Donà F; Tillhon M; Scovassi AI
Biochem Pharmacol; 2010 Dec; 80(12):1869-77. PubMed ID: 20417190
[TBL] [Abstract][Full Text] [Related]
36. Poly (adp-ribose) polymerase inhibitors as potential therapeutic agents in stroke and neurotrauma.
Komjáti K; Besson VC; Szabó C
Curr Drug Targets CNS Neurol Disord; 2005 Apr; 4(2):179-94. PubMed ID: 15857303
[TBL] [Abstract][Full Text] [Related]
37. Recent advances in understanding the role of oxidative stress in diabetic neuropathy.
Shakeel M
Diabetes Metab Syndr; 2015; 9(4):373-8. PubMed ID: 25470637
[TBL] [Abstract][Full Text] [Related]
38. Deleterious activation of poly(ADP-ribose)polymerase-1 in brain after in vivo oxidative stress.
Besson VC; Margaill I; Plotkine M; Marchand-Verrecchia C
Free Radic Res; 2003 Nov; 37(11):1201-8. PubMed ID: 14703732
[TBL] [Abstract][Full Text] [Related]
39. Poly(ADP-ribose) polymerase-mediated cell injury in acute renal failure.
Devalaraja-Narashimha K; Singaravelu K; Padanilam BJ
Pharmacol Res; 2005 Jul; 52(1):44-59. PubMed ID: 15911333
[TBL] [Abstract][Full Text] [Related]
40. Poly(ADP-ribose) polymerase-1 (PARP-1) inhibitors in cancer chemotherapy.
Cepeda V; Fuertes MA; Castilla J; Alonso C; Quevedo C; Soto M; Pérez JM
Recent Pat Anticancer Drug Discov; 2006 Jan; 1(1):39-53. PubMed ID: 18221025
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
